Cancer is often discussed as though it is one disease. It is not. It is a broad group of diseases in which abnormal cells grow uncontrollably, invade surrounding tissues and, in some cases, spread to other parts of the body. The disease can affect almost any organ. Yet for many Nigerians, the word “cancer” carries a meaning that goes beyond medicine. It can mean fear. It can mean expensive tests, long journeys to treatment centres, difficult decisions and the financial pressure that can come with prolonged care. And sometimes, it means discovering the disease only after it has become harder to treat.
The numbers show why the subject deserves more attention. The International Agency for Research on Cancer estimates that Nigeria recorded 127,763 new cancer cases and 79,542 cancer deaths in 2022. Breast cancer was the most frequently diagnosed cancer in the country, followed by prostate and cervical cancer. Those figures are estimates, but they provide a useful picture of the scale of the problem. Behind every number is a patient, a family and a health system trying to respond.
Cancer Is Not Always A Death Sentence
One of the most damaging ideas about cancer is that a diagnosis automatically means death. The World Health Organisation says many cancers can be cured when they are detected early and treated effectively. That makes early diagnosis important. It also changes the conversation.
Cancer control is not only about what happens after someone becomes seriously ill. It also involves prevention, awareness, screening where appropriate, early diagnosis, treatment, palliative care and follow-up. WHO’s 2026 global cancer report describes persistent inequalities across this entire chain, including differences in prevention, diagnosis, treatment and access to care. For Nigeria, the challenge is therefore not simply having cancer specialists or hospitals.
It is building a system in which people can move from suspicion to diagnosis and then to treatment without losing valuable time along the way.
The Cancers Nigerians Are Most Likely To Encounter
Nigeria’s cancer pattern is not identical to that of every other country. According to GLOBOCAN 2022 estimates, breast cancer accounted for 32,278 new cases among Nigerian women, making it the country’s most common cancer overall.
Prostate cancer followed with 18,019 cases, while cervical cancer accounted for 13,676. Colorectal cancer recorded 8,114 cases among both sexes. The figures also show differences between men and women.
Among Nigerian men, prostate cancer was the leading cancer by number of new cases, with 18,019 cases estimated in 2022. Among women, breast cancer was the leading cancer, followed by cervical cancer. These differences matter because cancer awareness cannot be a single message directed at everybody. The questions a man may need to discuss with a doctor are not necessarily the same as those facing a woman. Risk factors, symptoms and recommended screening approaches can also differ.
Why Finding Cancer Early Matters
Cancer becomes more difficult to manage when diagnosis is delayed. That does not mean every cancer discovered late is untreatable, nor that every cancer discovered early can be cured. But early detection can give patients more treatment options and improve the chances of better outcomes for many cancers. WHO distinguishes between screening and early diagnosis. Screening aims to identify people who may have a particular cancer or pre-cancer before symptoms appear. If an abnormality is found, further tests are required to establish whether cancer is actually present.
Early diagnosis, meanwhile, involves recognising possible symptoms and getting them assessed without unnecessary delay. That distinction is important. A screening test is not the same thing as a cancer diagnosis. A symptom is not proof of cancer either. But unexplained changes in the body should not simply be ignored because they are frightening or inconvenient.
The Cost Of Delay
For patients, delay can happen at several stages. Someone may not recognise a symptom. Another person may notice a change but decide to wait. Someone else may visit a health facility but need additional tests before a diagnosis can be made.
After diagnosis, there may be another challenge: finding and paying for treatment. Nigeria’s National Cancer Control Strategy 2023–2027 acknowledges major gaps in cancer infrastructure and specialist manpower. The strategy reported that, as of 2023, Nigeria had 12 comprehensive cancer treatment centres — six public and six private — alongside 58 oncologists and 11 medical physicists. For a country with a very large population, the figures help explain why access can be difficult.
Cancer care is also not a single treatment. Depending on the type and stage of cancer, care can involve surgery, chemotherapy, radiotherapy, medicines, pathology services and other forms of specialist support. Patients may also need pain management, psychological support, nutrition and rehabilitation. The national strategy identifies the need for multidisciplinary cancer services covering areas including oncology, surgery, radiation oncology, pathology, palliative care and rehabilitation.
When Geography Becomes Part Of The Problem
Cancer treatment is not equally accessible everywhere. The WHO’s 2026 cancer report highlights how geography can affect access to diagnosis and treatment, particularly for people living in rural areas who may have to travel long distances to reach specialised services. For a Nigerian patient, that journey may involve more than transport. There can be accommodation costs. There can be lost income for the patient or accompanying family member.
There can be repeated trips for consultations, tests or treatment. There can also be delays when a service is unavailable, and a patient has to be referred elsewhere. This is why cancer care cannot be measured only by the number of hospitals in a country. The question is also whether a patient can realistically reach the right service at the right time.
Prevention Is Part Of The Answer
Cancer prevention does not mean every case can be avoided. Some cancers are linked to inherited factors or circumstances that individuals cannot control. But WHO says a substantial proportion of cancer deaths are associated with preventable or modifiable risk factors, including tobacco use, alcohol consumption, excess body weight, inadequate fruit and vegetable intake and physical inactivity. Air pollution is also an important risk factor for lung cancer.
Some infections also play an important role. WHO estimates that cancer-causing infections such as human papillomavirus and hepatitis are responsible for about 30 per cent of cancer cases in low- and lower-middle-income countries.
This is particularly relevant to cervical cancer.
Prevention therefore includes more than telling people to “watch their lifestyle”. It can involve vaccination, infection prevention, appropriate screening, avoiding tobacco and reducing exposure to known risks.
The Problem Of Misinformation
Cancer also exists in an environment filled with myths. Some people still associate the disease with spiritual causes or believe that certain treatments can replace medical care. Others may fear biopsies, surgery or chemotherapy.
WHO has documented how misconceptions can contribute to late presentation. In one Nigerian cancer-awareness initiative highlighted by the organisation, health advocates described beliefs that women with breast lumps should avoid having the skin cut because it could make the condition worse.
Such beliefs can have serious consequences if they discourage people from seeking proper diagnosis. At the same time, the answer to misinformation is not to shame patients. Fear is often part of what makes cancer difficult to discuss.
People need clear information about what a symptom may mean, what tests are used to investigate it and why a doctor may recommend a particular treatment.
Screening Needs To Be Understood Properly
The word “screening” is now common in health conversations, but it can be misunderstood. Not every cancer has an effective population-wide screening programme. WHO says screening programmes are useful for some cancers but not all and require appropriate equipment, trained personnel and follow-up systems. Screening also works best when people with abnormal results can quickly move to diagnostic testing and, when necessary, treatment.
A screening programme without adequate follow-up can leave people knowing that something may be wrong without giving them a clear path to an answer. That is why cancer control has to be treated as a chain rather than a single service.
The Numbers Tell Only Part Of The Story
The 2022 Nigerian estimates — 127,763 new cases and 79,542 deaths — are stark. But they do not tell us everything about the experience of living with cancer. They do not capture the family member who accompanies a patient to hospital.
They do not measure the income lost during treatment. They do not fully capture the fear of waiting for a test result. They do not show the difference between someone who reaches treatment early and another person who arrives much later. And they cannot measure the effect of a diagnosis on an entire household. Cancer is therefore both a medical problem and a social one.
What Needs To Change?
Nigeria’s response to cancer requires progress at several levels. People need better information about risk factors and warning signs. Health workers need the capacity to recognise possible cancers and refer patients appropriately.
Diagnostic services need to be available and affordable enough to prevent avoidable delays. Treatment centres need trained specialists, equipment and reliable support systems. Patients also need access to palliative care and other services that help them live with serious illness.
The National Cancer Control Strategy recognises many of these needs, including stronger referral pathways, better health information systems and increased specialist capacity. The WHO’s latest global cancer report makes a similar point at a wider level: scientific progress is moving forward, but access to that progress remains unequal. Nigeria’s challenge is therefore not simply discovering better ways to treat cancer. It is making sure those advances can reach the people who need them.
Cancer will remain a serious health challenge. But the outcome does not have to be determined by fear, misinformation or delay. The more difficult question is whether Nigeria can build a system in which noticing something unusual leads quickly to the right test, the right diagnosis and, where necessary, the right treatment. That is where the real battle against cancer begins.